We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Australia Releases Costs, Details of Planned Premarket Reforms
Australia Releases Costs, Details of Planned Premarket Reforms
June 6, 2013
Australia’s Therapeutic Goods Administration is recommending to move forward with a proposal that would increase the number of mandatory audits for high-risk devices, make transparent all device regulatory decisions and allow all but Class IV in vitro diagnostic devicemakers to use non-TGA conformity assessments.
To View This Article:
Login
Subscribe To International Medical Device Regulatory Monitor